User profiles for Yihang Qi
 | Yihang QiHarvard Medical School Verified email at mgh.harvard.edu Cited by 382 |
Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer
The therapeutic effect of highly malignant triple negative breast cancer (TNBC) is negatively
affected by the formation of tumor cell resistant clone and the severe toxicity of …
affected by the formation of tumor cell resistant clone and the severe toxicity of …
[HTML][HTML] Research progress concerning dual blockade of lymphocyte-activation gene 3 and programmed death-1/programmed death-1 ligand-1 blockade in cancer …
Although various immunotherapies have exerted promising effects on cancer treatment, many
patients with cancer continue to exhibit poor responses. Because of its negative regulatory …
patients with cancer continue to exhibit poor responses. Because of its negative regulatory …
[HTML][HTML] PD-1/PD-L1 inhibitor-associated myocarditis: epidemiology, characteristics, diagnosis, treatment, and potential mechanism
Immune checkpoint inhibitors (ICIs) induce T-cell activation against cancer cells, and due to
their anti-tumor function in multiple cancers, ICIs have been considered an important option …
their anti-tumor function in multiple cancers, ICIs have been considered an important option …
[HTML][HTML] LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1
…, X Wang, K Zhang, X Yang, J Zhai, R Gao, Y Qi… - Cell death & …, 2019 - nature.com
Previously, several protein-coding tumor suppressors localized at 1p36 have been reported.
In the present work, we focus on functional long non-coding RNAs (lncRNAs) embedded in …
In the present work, we focus on functional long non-coding RNAs (lncRNAs) embedded in …
Immunological therapy: A novel thriving area for triple-negative breast cancer treatment
Triple-negative breast cancer (TNBC) refers to cancers that are low in expression of the
estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …
estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor …
Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data
There are minimal data regarding the prevalence of cancer in patients with coronavirus
disease 2019 (COVID-19), as well as the incidence of severe illness and rate of mortality in …
disease 2019 (COVID-19), as well as the incidence of severe illness and rate of mortality in …
Ginsenoside Rg1 reverses stress‐induced depression‐like behaviours and brain‐derived neurotrophic factor expression within the prefrontal cortex
X Zhu, R Gao, Z Liu, Z Cheng, Y Qi… - European Journal of …, 2016 - Wiley Online Library
Depression is a major neuropsychiatric disorder that exerts deleterious effects upon public
health. However, the neuronal mechanisms of depression remain largely uncharacterized, …
health. However, the neuronal mechanisms of depression remain largely uncharacterized, …
[HTML][HTML] Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer
Background: The combination of immune checkpoint inhibitors (ICIs) and chemotherapy (CT)
is a new strategy to explore cancer treatment in recent years, and it is also practiced in triple…
is a new strategy to explore cancer treatment in recent years, and it is also practiced in triple…
[HTML][HTML] Molecular and clinical characterization of LAG3 in breast cancer through 2994 samples
Despite the promising impact of cancer immunotherapy targeting CTLA4 and PD1/PDL1,
numerous cancer patients fail to respond. LAG3 (Lymphocyte Activating 3), also named CD233…
numerous cancer patients fail to respond. LAG3 (Lymphocyte Activating 3), also named CD233…
[HTML][HTML] Efficacy and safety of anti-PD-1/PD-L1 monotherapy for metastatic breast cancer: clinical evidence
Background: Success has been reported in PD-1/PD-L1 blockade via pembrolizumab,
atezolizumab, or avelumab monotherapy in manifold malignancies including metastatic breast …
atezolizumab, or avelumab monotherapy in manifold malignancies including metastatic breast …
